Lionheart Health Recognized as Finalist for Medical Technology Innovation Award
TL;DR
Lionheart Health's FDA-cleared bioelectric technology offers clinics a competitive edge by licensing advanced longevity solutions that can attract high-value healthspan clients.
Lionheart Health's AI-powered regeneration chamber uses bioelectrically-controlled biologics to systematically regenerate organs and extend healthspan through precise robotic interventions.
Lionheart Health's innovations in healthspan longevity create a better world by enabling people to live healthier, longer lives through regenerative medical technology.
Lionheart Health's adult regeneration chamber acts like a womb to potentially extend healthspan by 20 years using AI and bioelectric stimulation.
Found this article helpful?
Share it with your network and spread the knowledge!
Lionheart Health, Inc. has been selected as a finalist in the Best Innovation in Medical Technology Life Sciences category at Octane's prestigious High Tech Awards, recognizing the company's work in healthspan longevity and medical aesthetics. The Orange County-based innovation leader is being honored for its development of advanced bioelectric and biologics technologies designed to extend human healthspan. The company's flagship development is a whole body regeneration chamber described as a "womb for adults" that utilizes AI and precise robotics to regenerate multiple organs including hearts, kidneys, brains, livers, and pancreas. This multi-modality device, powered by bioelectrically-controlled enhanced biologics, aims to extend healthspan longevity by 20 years while addressing circulation, muscle strength, pain reduction, and inflammation.
Lionheart Health's business model focuses on licensing its patented technology platform to qualified clinics worldwide. The company has secured FDA 510K market clearances for using targeted bioelectric stimulation to improve various health conditions. These technologies are integrated into products addressing skin and hair health, sexual health vitality, joint pain recovery, rapid body toning, and chronic inflammation reduction. Howard Leonhardt, Executive Chairman and Co-CEO, stated that this recognition demonstrates the company's dedication to advancing longevity through innovation. The company maintains its world headquarters in Huntington Beach, California, with additional facilities including an R&D Lab in Irvine at UCI Research Park and a Research Clinic and Training Center in Newport Beach. More information about their longevity initiatives can be found at http://www.LionheartLongevity.com.
This award nomination adds to Lionheart Health's growing list of recognitions, including the AbbVie Allergan ULP Innovation in Medical Aesthetics Award and Medtech Outlook Stimulator Development of the Year 2025 Award. The company is also among 40 semi-finalists in the $101 million XPRIZE Healthspan Competition and was recently named a finalist for the Orange County Business Journal Innovator of the Year 2025 Award. The Octane 2025 Technology Awards Ceremony will take place on September 25th, 2025, in Irvine. Registration details are available at https://www.octane-oc.org/event/e891a457-c212-43fa-9c31-c35a57002cd9/2025-finalists. Lionheart Health is also sponsoring The Klotho Conference in Irvine on September 15th and 16th, 2025, focusing on healthspan extension through klotho level elevation.
Curated from Newsworthy.ai
